Friday, June 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 153 of 1,261

  1. US 11834413

    Antiplatelet drugs and uses thereof

    SHANGHAI CUREGENE PHARMACEUTICAL CO., LTD. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  2. US 11834439

    Compounds, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  3. US 11833157

    Precipitation resistant small molecule drug formulations

    XERIS PHARMACEUTICALS, INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  4. US 11834512

    Inhibiting anti-ENPP1 antibodies

    The Regents of the University of California · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  5. US 11834649

    CRISPR/CAS-related methods and compositions for treating herpes simplex virus

    Editas Medicine, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  6. US 11834640

    Device and uses thereof for treating diabetes

    The Board of Regents of the University of Texas System · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  7. US 11833171

    Materials and methods relating to stabilised polymeric silicate compositions

    United Kingdom Research and Innovation · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  8. US 11834515

    Macrocyclic compounds as proteasome inhibitors

    Tri-Institutional Therapeutics Discovery Institute, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  9. US 11834688

    Ligase fusion proteins and application thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  10. US 11834662

    Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  11. US 11834660

    Compositions for modulating Ataxin 2 expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  12. US 11834553

    Alkoxylation methods

    Nektar Therapeutics · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  13. US 11833254

    Discoidal nano universal platform for efficient delivery of PNAs

    UNIVERSITY OF CONNECTICUT · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  14. US 11833205

    Kaolinite composite diagnostic and therapeutic agent and preparation method and use thereof

    China University of Geosciences · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  15. US 11834500

    Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  16. US 11833148

    Methods for treating or limiting development of cardiovascular disease-related neurological disorders

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  17. US 11834485

    IL-2 variants with reduced binding to IL-2 receptor alpha and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  18. US 11833130

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  19. US 11833159

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  20. US 11833172

    Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue regeneration

    The Regents of the University of Colorado · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  21. US 11833196

    Compositions and methods for delivery of biomacromolecule agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  22. US 11833225

    Methods and compositions for efficient gene deletion

    CRISPR THERAPEUTICS AG · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  23. US 11834462

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  24. US 11834409

    Heterocyclic NMDA antagonists

    Takeda Pharmaceutical Company Limited · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.